Cargando…
Irinotecan combined with oxaliplatin and S-1 in patients with metastatic pancreatic adenocarcinoma: a single-arm, three-centre, prospective study
OBJECTIVE: To study the efficacy and toxicity of irinotecan combined with oxaliplatin and S-1 in patients with metastatic pancreatic adenocarcinoma. PATIENTS AND METHODS: Previously untreated patients with cytologically or histologically confirmed metastatic pancreatic adenocarcinoma underwent a tre...
Autores principales: | Nie, Keke, Zhang, Ling, You, Yunhong, Li, Hongmei, Guo, Xiuhui, Zhang, Zhongfa, Zhang, Chunling, Ji, Youxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675906/ https://www.ncbi.nlm.nih.gov/pubmed/33240399 http://dx.doi.org/10.1177/1758835920970843 |
Ejemplares similares
-
S-1 Maintenance Therapy in Extensive Stage Small-Cell Lung Cancer—A
Randomized Clinical Study
por: Nie, Keke, et al.
Publicado: (2020) -
Irinotecan, docetaxel and oxaliplatin combination in metastatic gastric or gastroesophageal junction adenocarcinoma
por: Di Lauro, L, et al.
Publicado: (2007) -
A randomized clinical study to compare intrapleural infusion with intravenous infusion of bevacizumab in the management of malignant pleural effusion in patients with non‐small‐cell lung cancer
por: Nie, Keke, et al.
Publicado: (2019) -
Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma
por: Frampton, James E.
Publicado: (2020) -
Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
por: Aparicio, T, et al.
Publicado: (2003)